These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35468028)

  • 1. Cholecalciferol complexation with hydroxypropyl-β-cyclodextrin (HPBCD) and its molecular dynamics simulation.
    Wang F; Yu W; Popescu C; Ibrahim AA; Yu D; Pearson R; MacKerell AD; Hoag SW
    Pharm Dev Technol; 2022 Apr; 27(4):389-398. PubMed ID: 35468028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique.
    Mihajlovic T; Kachrimanis K; Graovac A; Djuric Z; Ibric S
    AAPS PharmSciTech; 2012 Jun; 13(2):623-31. PubMed ID: 22535520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of budesonide- and indomethacin-hydroxypropyl-beta-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process.
    Bandi N; Wei W; Roberts CB; Kotra LP; Kompella UB
    Eur J Pharm Sci; 2004 Oct; 23(2):159-68. PubMed ID: 15451004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
    Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
    Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATR/Raman and fractal characterization of HPBCD/progesterone complex solid particles.
    Fini A; Ospitali F; Zoppetti G; Puppini N
    Pharm Res; 2008 Sep; 25(9):2030-40. PubMed ID: 18597163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
    Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
    Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-
    Han D; Han Z; Liu L; Wang Y; Xin S; Zhang H; Yu Z
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex].
    Zhang YM; Li X; Sun CS; Chen CF
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Mar; 28(3):711-4. PubMed ID: 18536450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Dynamic Simulation Analysis on the Inclusion Complexation of Plumbagin with β-Cyclodextrin Derivatives in Aqueous Solution.
    Jitapunkul K; Toochinda P; Lawtrakul L
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion complex of saikosaponin-d with hydroxypropyl-β-cyclodextrin: Improved physicochemical properties and anti-skin cancer activity.
    Hu SC; Lai YC; Lin CL; Tzeng WS; Yen FL
    Phytomedicine; 2019 Apr; 57():174-182. PubMed ID: 30776588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difluprednate-Hydroxypropyl-β-Cyclodextrin-Based Ophthalmic Solution for Improved Delivery in a Porcine Eye Model.
    Shelley H; Annaji M; Smith FT; Babu RJ
    J Ocul Pharmacol Ther; 2022; 38(1):92-101. PubMed ID: 34665027
    [No Abstract]   [Full Text] [Related]  

  • 14. Complexation study of the anticancer agent EO-9 with 2-hydroxypropyl-beta-cyclodextrin.
    Beijnen JH; van der Schoot SC; Nuijen B; Flesch FM; Gore A; Mirejovsky D; Lenaz L
    Drug Dev Ind Pharm; 2008 Oct; 34(10):1130-9. PubMed ID: 18663657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid state characterization of progesterone in a freeze dried 1:2 progesterone/HPBCD mixture.
    Zoppetti G; Puppini N; Ospitali F; Fini A
    J Pharm Sci; 2007 Jul; 96(7):1729-36. PubMed ID: 17514727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
    Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS
    Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-state characterization and in vitro dissolution behavior of lorazepam: Hydroxypropyl-β-cyclodextrin inclusion complex.
    Patel R; Patel M
    Drug Discov Ther; 2010 Dec; 4(6):442-52. PubMed ID: 22491310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.
    Jambhekar S; Casella R; Maher T
    Int J Pharm; 2004 Feb; 270(1-2):149-66. PubMed ID: 14726131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.
    Wang D; Li H; Gu J; Guo T; Yang S; Guo Z; Zhang X; Zhu W; Zhang J
    J Pharm Biomed Anal; 2013 Sep; 83():141-8. PubMed ID: 23732534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.